Health Care UltraSector ProFund
The Health Care UltraSector ProFund seeks daily investment results, before fees and expenses, that are 1.5x the return of the Dow Jones U.S. Health CareSM Index (the "Index") for a single day.
View Prospectus
Fund Snapshot
Fund Snapshot
|
Investor Class |
Service Class |
| Ticker |
HCPIX |
HCPSX
|
| CUSIP |
743185373 |
743185365
|
| Fund Number |
049 |
079
|
| Inception Date |
6/19/2000
|
| Fund Group |
Sector ProFunds - UltraSector |
Fund Statistics
Fund Statistics
| Limits On Exchanges |
None |
| Minimum Investment |
| Individual Investor |
$15,000 |
| Financial Professionals |
$5,000 |
Returns (as of 3/31/2013)
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the original cost. For standardized returns year-to-date and as of the most recent calendar quarter-end, see performance Returns include the reinvestment of dividends and capital gains.
Returns include the reinvestment of dividends and capital gains.
Returns (as of 3/31/2013)
| YTD (as of 5/20/2013) |
35.34% |
| Average Annual One Year |
37.56% |
| Average Annual Three Year |
20.79% |
| Average Annual Five Year |
12.80% |
| Average Annual Ten Year |
8.78% |
| Average Annual Since Inception |
2.06% |
| Cumulative Since Inception |
29.71% |
| Gross Expense Ratio |
2.15% |
| Net Expense Ratio |
1.73% |
All data, unless otherwise noted, is as of 3/31/2013 and for Investor Class Shares only and is subject to change.
Index/Benchmark
Dow Jones U.S. Health Care Index
The Index (Bloomberg symbol: DJUSHC) measures the performance of the healthcare sector of the U.S. equity market. Component companies include, among others, health care providers, biotechnology companies, medical supplies, advanced medical devices and pharmaceuticals. It is not possible to invest directly in an index.
| Total Index Companies |
113 |
| Price/Earnings Ratio |
19.32 |
| Price/Book Ratio |
3.27 |
| Dividend Yield |
1.85% |
| Average Index Market Capitalization |
16.76 billion
|
Index as of 3/31/2013
| Index Sector Weightings |
Weight |
|
Pharmaceuticals & Biotechnology
|
67.48%
|
|
Health Care Equipment & Services
|
32.52%
|
As of 3/31/2013
| Top 10 Index Companies |
Weight |
|
Johnson & Johnson
|
12.03%
|
|
Pfizer Inc.
|
10.95%
|
|
Merck & Co Inc.
|
7.06%
|
|
Amgen Inc.
|
4.05%
|
|
Gilead Sciences Inc.
|
3.93%
|
|
Bristol-Myers Squibb Co.
|
3.56%
|
|
AbbVie Inc.
|
3.40%
|
|
UnitedHealth Group Inc.
|
3.10%
|
|
Eli Lilly and Co.
|
2.99%
|
|
Abbott Laboratories
|
2.93%
|
Narrowly focused investments typically exhibit higher volatility.